Skip to main content
Clinical Trials/IRCT20200128046289N1
IRCT20200128046289N1
Recruiting
Phase 3

comparison of efficacy of two treatment regimen,cefazolin alone with cefazolin plus metronidazol in the prevention of surgical site infections after hysterectomy

Babol University of Medical Sciences0 sites400 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Skin Site Infection after Hysterectomy.
Sponsor
Babol University of Medical Sciences
Enrollment
400
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • All women who are candidates for hysterectomy

Exclusion Criteria

  • Sensitivities to cefazolin
  • Sensitivities to metronidazole
  • sensitivities to penicillins

Outcomes

Primary Outcomes

Not specified

Similar Trials